JPH09124593A5 - - Google Patents

Info

Publication number
JPH09124593A5
JPH09124593A5 JP1996237163A JP23716396A JPH09124593A5 JP H09124593 A5 JPH09124593 A5 JP H09124593A5 JP 1996237163 A JP1996237163 A JP 1996237163A JP 23716396 A JP23716396 A JP 23716396A JP H09124593 A5 JPH09124593 A5 JP H09124593A5
Authority
JP
Japan
Prior art keywords
administered
dose
effect
solubilizer
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1996237163A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09124593A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP8237163A priority Critical patent/JPH09124593A/ja
Priority claimed from JP8237163A external-priority patent/JPH09124593A/ja
Publication of JPH09124593A publication Critical patent/JPH09124593A/ja
Publication of JPH09124593A5 publication Critical patent/JPH09124593A5/ja
Pending legal-status Critical Current

Links

JP8237163A 1995-08-25 1996-08-20 プロスタグランジンｅ１エステル、それらを含有するリポソーム製剤、およびそれらを含有する医薬 Pending JPH09124593A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8237163A JPH09124593A (ja) 1995-08-25 1996-08-20 プロスタグランジンｅ１エステル、それらを含有するリポソーム製剤、およびそれらを含有する医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-238984 1995-08-25
JP23898495 1995-08-25
JP8237163A JPH09124593A (ja) 1995-08-25 1996-08-20 プロスタグランジンｅ１エステル、それらを含有するリポソーム製剤、およびそれらを含有する医薬

Publications (2)

Publication Number Publication Date
JPH09124593A JPH09124593A (ja) 1997-05-13
JPH09124593A5 true JPH09124593A5 (https=) 2004-07-15

Family

ID=26533082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8237163A Pending JPH09124593A (ja) 1995-08-25 1996-08-20 プロスタグランジンｅ１エステル、それらを含有するリポソーム製剤、およびそれらを含有する医薬

Country Status (1)

Country Link
JP (1) JPH09124593A (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2313900T3 (es) * 1999-07-28 2009-03-16 The Board Of Trustees Of The Leland Stanford Junior University Nicotina en angiogenesis y vasculogenesis terapeutica.
US8916206B2 (en) 2005-12-26 2014-12-23 Ltt Bio-Pharma Co., Ltd. Nanoparticles containing water-soluble non-peptide low-molecular weight drug
CN102216310A (zh) * 2008-11-18 2011-10-12 日本株式会社Ltt生物医药 新型前列腺素e1衍生物以及包封了该前列腺素e1衍生物的纳米粒子
AU2010253720A1 (en) * 2009-05-27 2011-12-08 Osaka University Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders

Similar Documents

Publication Publication Date Title
US12090139B2 (en) Formulations comprising triptan compounds
KR960033470A (ko) 정맥내 투여용 나노현탁액
WO2004110346A3 (en) Sustained release of antiinfectives
CA2162993A1 (en) Solid fat nanoemulsions as drug delivery vehicles
CA2215327A1 (en) Formulations for lipophilic compounds
CA2087146A1 (en) Flavour-masked pharmaceutical compositions
WO1997006813A1 (en) Mucosal preparation containing physiologically active peptide
CA2170622A1 (en) Oral Formulations of an Antifungal
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
CA1238275A (en) Menthol enhancement of transdermal drug delivery
WO2000004894A3 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
EP1138323A3 (en) Resveratrol for the treatment of exfoliative eczema, acne or psoriasis
HUE026166T2 (en) New epoprosthenol preparation and procedure
NO971683L (no) Lyofilisert farmasöytisk preparat som gjör vandige medikamentblandinger reversibelt termogelatinerende
KR20090064597A (ko) 안정화된 프로스타글란딘 ｅ 조성물
WO1989003673A1 (fr) Medicament comprenant l'association de polymyxine b, de tobramycine et d'amphotericine b administre par vaporisation
US6007834A (en) Nasal melatonin composition
WO2005048985A3 (en) Alpha 1-antitrypsin compositions and treatment methods using such compositions
WO1989005139A1 (fr) Medicament comprenant l'association de colistine, de tobramycine et d'amphotericine b administree par vaporisation
WO1989003672A1 (fr) Medicament comprenant l'association de polymyxine b, de netilmicine et d'amphotericine b administre par vaporisation
JPH09124593A5 (https=)
SE9801647D0 (sv) Therapeutic composition
JP2905210B2 (ja) 経皮、経粘膜吸収促進剤および経皮、経粘膜製剤
US11337962B2 (en) Formulations comprising triptan compounds
EP0867181A1 (en) Nasal melatonin composition